Literature DB >> 7923005

Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva.

D Paladini1, P Cross, A Lopes, J M Monaghan.   

Abstract

BACKGROUND: In patients with squamous cell carcinoma of the vulva, lymph nodal, surgicopathologic variables have been studied rarely, although lymph node status is by far the most important prognostic factor. This study was designed to investigate surgicopathologic variables of lymph node metastases to evaluate their prognostic significance.
METHODS: In 75 patients with inguinal and/or pelvic lymph node metastases from squamous cell carcinoma of the vulva, the following parameters were studied: size and location of the tumor, depth of invasion, grade, lymph-vascular space involvement (LVSI), local immune reaction, presence and degree of dystrophic changes in the surrounding skin, FIGO stage, number of positive lymph nodes, greatest dimension of the metastasis within the lymph node, percentage of lymph node replacement, number of lymph nodes with replacement greater than 50%, number of lymph nodes replaced completely by tumor, extracapsular spread, and active immunologic response within the lymph node.
RESULTS: Among the variables related to the primary carcinomas, only size of the tumor and LVSI were correlated with survival (P < 0.003 and P < 0.02, respectively). On the contrary, all pathologic variables regarding the lymph nodes significantly influenced survival by univariate analysis. On multivariate analysis, extracapsular spread was the most significant independent prognostic factor (P < 0.0004), followed by FIGO stage (P < 0.03). For patients with only one positive lymph node, the most important prognostic factor was the greatest dimension of the metastasis within the lymph node (P < 0.01).
CONCLUSIONS: These data, if confirmed in larger series, can contribute to a more accurate identification of low and high risk patients and, therefore, to a more appropriate employment of adjuvant therapies.

Entities:  

Mesh:

Year:  1994        PMID: 7923005     DOI: 10.1002/1097-0142(19941101)74:9<2491::aid-cncr2820740916>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  Detection of tumour lymphovascular space invasion using dual cytokeratin and CD31 immunohistochemistry.

Authors:  F Alexander-Sefre; N Singh; A Ayhan; H B Salveson; G Wilbanks; I J Jacobs
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

Review 2.  Management of lymph nodes in the treatment of vulvar cancer.

Authors:  Toshiaki Saito; Keiji Kato
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

3.  Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer.

Authors:  Ricardo dos Reis; Jennifer K Burzawa; Audrey T Tsunoda; Masayoshi Hosaka; Michael Frumovitz; Shannon N Westin; Mark F Munsell; Pedro T Ramirez
Journal:  Int J Gynecol Cancer       Date:  2015-09       Impact factor: 3.437

4.  Management of patients with vulvar cancer: a perspective review according to tumour stage.

Authors:  Linn Woelber; Fabian Trillsch; Lilli Kock; Donata Grimm; Cordula Petersen; Matthias Choschzick; Fritz Jaenicke; Sven Mahner
Journal:  Ther Adv Med Oncol       Date:  2013-05       Impact factor: 8.168

5.  [Changes in the TNM classification of gynecological tumors].

Authors:  L-C Horn; M W Beckmann; A Beller; D Schmidt; U Ulrich; P Hantschmann; C Wittekind
Journal:  Pathologe       Date:  2010-09       Impact factor: 1.011

Review 6.  Vulvar carcinoma.

Authors:  R L Coleman; J T Santoso
Journal:  Curr Treat Options Oncol       Date:  2000-06

7.  Immunomorphological patterns of cervical lymph nodes in oral squamous cell carcinoma.

Authors:  Vidyadevi Chandavarkar; K Uma; R Sangeetha; Mithilesh Mishra
Journal:  J Oral Maxillofac Pathol       Date:  2014 Sep-Dec

8.  Defining the concept of locally advanced squamous cell carcinoma of the vulva: a new perspective based on standardization of criteria and current evidence.

Authors:  Alejandro M Aragona; Alejandro H Soderini; Nicasio A Cuneo
Journal:  J Gynecol Oncol       Date:  2014-07-06       Impact factor: 4.401

9.  Serum DNA integrity index as a potential molecular biomarker in endometrial cancer.

Authors:  Enrico Vizza; Giacomo Corrado; Martina De Angeli; Mariantonia Carosi; Emanuela Mancini; Ermelinda Baiocco; Benito Chiofalo; Lodovico Patrizi; Ashanti Zampa; Giulia Piaggio; Lucia Cicchillitti
Journal:  J Exp Clin Cancer Res       Date:  2018-01-30

10.  Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer.

Authors:  Toshiaki Saito; Tsutomu Tabata; Hitoshi Ikushima; Hiroyuki Yanai; Hironori Tashiro; Hitoshi Niikura; Takeo Minaguchi; Toshinari Muramatsu; Tsukasa Baba; Wataru Yamagami; Kazuya Ariyoshi; Kimio Ushijima; Mikio Mikami; Satoru Nagase; Masanori Kaneuchi; Nobuo Yaegashi; Yasuhiro Udagawa; Hidetaka Katabuchi
Journal:  Int J Clin Oncol       Date:  2017-11-20       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.